Bausch Health Companies (BHC) Other Non-Current Assets (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Other Non-Current Assets came in at $369.0 million in Q1 2026, down 2.89% year-on-year from $380.0 million in Q1 2025, and down 2.38% quarter-over-quarter from $378.0 million in Q4 2025.

Bausch Health Companies (BHC) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $369.0 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $369.0 million, down 2.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $369.0 million (down 2.89% YoY), and the FY2025 annual result was $378.0 million, up 4.13% from the prior year.
  • Other Non-Current Assets came in at $369.0 million for Q1 2026 at Bausch Health Companies, down from $378.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $389.0 million in Q3 2024 to a low of $307.0 million in Q4 2023.
  • The 5-year median for Other Non-Current Assets is $338.0 million (2022), against an average of $347.5 million.
  • Across the five-year window, Other Non-Current Assets tumbled 45.87% in 2022 and advanced 21.79% in 2025, its largest moves.
  • Bausch Health Companies' Other Non-Current Assets stood at $326.0 million in 2022, then fell by 5.83% to $307.0 million in 2023, then climbed by 18.24% to $363.0 million in 2024, then grew by 4.13% to $378.0 million in 2025, then slipped by 2.38% to $369.0 million in 2026.
  • The last three Other Non-Current Assets figures came in at $369.0 million (Q1 2026), $378.0 million (Q4 2025), and $382.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.79 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 59.36 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 47.63 Mn
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn 369.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 369.00 Mn
Dec 31, 2025 378.00 Mn
Sep 30, 2025 382.00 Mn
Jun 30, 2025 388.00 Mn
Mar 31, 2025 380.00 Mn
Dec 31, 2024 363.00 Mn
Sep 30, 2024 389.00 Mn
Jun 30, 2024 329.00 Mn
Mar 31, 2024 312.00 Mn
Dec 31, 2023 307.00 Mn
Sep 30, 2023 328.00 Mn
Jun 30, 2023 325.00 Mn
Mar 31, 2023 318.00 Mn
Dec 31, 2022 326.00 Mn
Sep 30, 2022 341.00 Mn
Jun 30, 2022 338.00 Mn
Mar 31, 2022 334.00 Mn
Dec 31, 2021 340.00 Mn
Sep 30, 2021 343.00 Mn
Jun 30, 2021 596.00 Mn